Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors

References

• Takenaka Y, Uno A, Tanaka H, et al. Distant metastasis in head and neck squamous cell carcinoma variants: a population-based study. Head Neck. 2023;45(4):882–889. doi: 10.1002/hed.27305.
   PubMed Web of Science ®Google Scholar
• Cho H, Nishiike S, Yamamoto Y, et al. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma. Auris Nasus Larynx. 2015;42(5):396–400. doi: 10.1016/j.anl.2015.02.009.
   PubMed Web of Science ®Google Scholar
• Kao HF, Lou PJ. Immune checkpoint inhibitors for head and neck squamous cell carcinoma: current landscape and future directions. Head Neck. 2019;41 Suppl 1(S1):4–18. doi: 10.1002/hed.25930.
   PubMedGoogle Scholar
• Van Wilpe S, Koornstra R, Den Brok M, et al. Lactate dehydrogenase: a marker of diminished antitumor immunity. Oncoimmunology. 2020;9(1):1731942. doi: 10.1080/2162402X.2020.1731942.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Oya R, Aoki K, et al. Pretreatment serum lactate dehydrogenase as a prognostic indicator for oral cavity squamous cell carcinoma. Acta Otolaryngol. 2018;138(4):433–436. doi: 10.1080/00016489.2017.1398839.
   PubMed Web of Science ®Google Scholar
• Keung EZ, Gershenwald JE. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018;18(8):775–784. doi: 10.1080/14737140.2018.1489246.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi: 10.1016/j.ejca.2008.10.026.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Petrelli F, Cabiddu M, Coinu A, et al. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol. 2015;54(7):961–970. doi: 10.3109/0284186X.2015.1043026.
   PubMed Web of Science ®Google Scholar
• Chang CH, Qiu J, O’Sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell. 2015;162(6):1229–1241. doi: 10.1016/j.cell.2015.08.016.
   PubMed Web of Science ®Google Scholar
• Brand A, Singer K, Koehl GE, et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 2016;24(5):657–671. doi: 10.1016/j.cmet.2016.08.011.
   PubMed Web of Science ®Google Scholar
• Pan C, Wu QV, Voutsinas J, et al. Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors. Cancer Med. 2023;12(8):9384–9391. doi: 10.1002/cam4.5697.
   PubMed Web of Science ®Google Scholar
• Issa M, Klamer BG, Mladkova N, et al. Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort. BMC Cancer. 2022;22(1):767. doi: 10.1186/s12885-022-09809-5.
   PubMed Web of Science ®Google Scholar
• Nenclares P, Gunn L, Soliman H, et al. On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy. J Immunother Cancer. 2021;9(6):e002718. doi: 10.1136/jitc-2021-002718.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Takemoto N, Otsuka T, et al. Validation and comparison of prognostic scoring systems in patients with head and neck squamous cell carcinoma treated with nivolumab. Jpn J Clin Oncol. 2024;54(7):761–769. doi: 10.1093/jjco/hyae042.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Oya R, Takemoto N, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: meta-analysis. Head Neck. 2022;44(5):1237–1245. doi: 10.1002/hed.26997.
   PubMed Web of Science ®Google Scholar
• Guo Y, Xiang D, Wan J, et al. Focus on the dynamics of neutrophil-to-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Cancers (Basel). 2022;14(21):5297. doi: 10.3390/cancers14215297.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Takemoto N, Otsuka T, et al. Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: a multicenter retrospective study. Oral Oncol. 2022;132:106018. doi: 10.1016/j.oraloncology.2022.106018.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Oya R, Takemoto N, et al. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis. J Cachexia Sarcopenia Muscle. 2021;12(5):1122–1135. doi: 10.1002/jcsm.12755.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Oya R, Kitamiura T, et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: a meta-analysis. Head Neck. 2018;40(3):647–655. doi: 10.1002/hed.24986.
   PubMed Web of Science ®Google Scholar
• Li M, Spakowicz D, Burkart J, et al. Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers. J Cancer Res Clin Oncol. 2019;145(10):2541–2546. doi: 10.1007/s00432-019-02982-4.
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Takemoto N, Oya R, et al. Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis. PLoS One. 2021;16(10):e0259288. doi: 10.1371/journal.pone.0259288.
   PubMed Web of Science ®Google Scholar
• Loosen SH, van den Bosch V, Gorgulho J, et al. Progressive sarcopenia correlates with poor response and outcome to immune checkpoint inhibitor therapy. J Clin Med. 2021;10(7):1361. doi: 10.3390/jcm10071361.
   PubMed Web of Science ®Google Scholar